Botanical species · safety record

Boswellia serrata

The EFSA Compendium of Botanicals holds 2 adverse-effect records for Boswellia serrata. This page reports what those source records contain and how to reach them. It carries no effect estimate, no dose and no recommendation.

Accepted name in source: Boswellia serrata Roxb. ex Colebr.

0Constituent measurements
2Safety records
2Cited sources
777Licensed products (Canada)

Regulatory presence

Health Canada's Licensed Natural Health Products Database holds 777 licensed products naming Boswellia serrata as a medicinal ingredient, matched on the exact Latin binomial. A licence records that a product met the regulator's requirements for sale in Canada. It is not evidence that the product works.

Extract types on licence

  • Dry
  • Extract Type TBA
  • Fresh

Source material stated

  • Aged bark
  • Bark
  • Bark (trunk)
  • Bark resin
  • Boswellia sacra - stem bark resin
  • Boswellia serrata
  • Boswellia serrata (Stem oleogum resin)
  • Boswellia serrata - Oléorésine (écorce de tronc)

What the records describe

Effect types

  • Other toxicities1
  • Reproductive1

Target tissues

  • Uterus1

Recorded adverse effects

Adverse effects reported in the source literature, most often in animal or laboratory models at a stated preparation and dose.

EffectTarget tissuePlant partPreparationTest organismTest typeSource
Other toxicitiesRat (as animal)SubchronicResolve DOI
ReproductiveUterusReproduction toxicityNo resolvable identifier

Cited sources

The literature the compendium cites for this species. Metatron Health has no relationship with these authors or journals and earns nothing from citing them.

  1. Singh, Pooja., Chacko, K Mathai., Aggarwal, M L., Bhat, Binu., Khandal, R K., Sultana, Sarwat., Kuruvilla, Binu T. A-90 Day Gavage Safety Assessment of Boswellia serrata in Rats.. Toxicology international, 2012, vol. 19, no. 3, p. 273-8. DOI
  2. Basch, Ethan., Boon, Heather., Davies-Heerema, Theresa., Foppo, Ivo., Hashmi, Sadaf., Hasskarl, Jens., Sollars, David., Ulbricht, Catherine. Boswellia: An evidence-based systematic review by the Natural Standard Research Collaboration . Journal of herbal pharmacotherapy, 2004, vol. 4, no. 3, p. 63-83.

Boundary

A constituent measurement is a fact about material at a stated preparation, not a statement about what that material does in a person. An adverse-effect or genotoxicity record is an observation reported in a source, most often in an animal or laboratory model. Neither is a Metatron Health conclusion about causality, human risk or benefit, and the absence of a record is not proof that a preparation is safe. Nothing here is diagnosis, prescribing or individual medical care.

Continue